Why experts have put buy recommendations on these ASX shares

When sentiment improves after sharp falls, opportunities can start to emerge.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I don't base investment decisions purely on broker recommendations, but I do pay close attention when analysts turn more positive after a period of share price weakness. Quite often, that combination of falling prices and improving fundamentals is where the most interesting opportunities start to appear.

Right now, several well-known ASX shares have buy recommendations from brokers who believe the outlook is improving. These are three where I can see the logic behind the optimism.

A young woman drinking coffee in a cafe smiles as she checks her phone.

Image source: Getty Images

WiseTech Global Ltd (ASX: WTC)

WiseTech's share price has been under significant pressure, and in my view, much of that negativity has already been well aired. Bell Potter notes that the pullback has been driven by company-specific issues such as "slowing growth in the core business, management and board upheaval and insider trading allegations against CEO and founder Richard White."

Importantly, the broker believes that "these issues, however, are starting to subside and focus is returning to the outlook for the core business." That resonates with me. When sentiment becomes this negative, it does not take perfection to drive a recovery, just stabilisation and improving execution.

Bell Potter points to "the launch of new products, a new commercial model and the integration of a large acquisition (e2open)" as key drivers of a stronger second half. It expects "a much stronger 2HFY26 result relative to 1HFY26," with FY27 being the first year to fully reflect the benefits.

There are still risks, including the possibility of a soft downgrade to FY26 guidance, but I think Bell Potter's view that "the 12-month outlook is positive" is reasonable. The broker has a buy recommendation and a $100 price target on the shares.

Xero Ltd (ASX: XRO)

Xero is an ASX share I have long admired for its execution, and I find Macquarie's commentary particularly encouraging.

The broker says management is "walking the walk, making data-driven decisions that invariably lead to better capital allocation outcomes." That aligns with how I see the business. Xero has become far more disciplined as it has scaled, and that matters as it tackles a market as large as the United States.

Macquarie highlights that it has "high conviction in >12mo story, driven by the US opportunity," with Gusto and Melio described as "the platform for US growth." I agree with that assessment. The US remains the key swing factor for Xero's long-term valuation, and management appears to be moving with care and urgency.

Macquarie has an outperform recommendation and a $230.30 price target. While the journey will not be linear, I think the broker's confidence in Xero's medium-term story is well placed.

Aristocrat Leisure Ltd (ASX: ALL)

Aristocrat's latest result was not without its softer points, but I think Morgans makes a fair argument that the market reaction has been too harsh.

The broker described the FY25 result as "solid," with "healthy yoy growth following the sale of Plarium and full inclusion of NeoGames." It acknowledged weaker performance in Interactive and softer trends in North American Gaming Operations, but also noted that management expects the business to "return to its normalised growth range moving forward."

What stood out to me was Morgans' view that it sees "no structural shift in market dynamics." That is important. Short-term execution issues are one thing, but structural change is what really breaks investment cases.

Despite trimming earnings forecasts slightly, Morgans believes recent share price weakness has created "a more compelling valuation." That was enough for the broker to upgrade the shares from accumulate to buy, with a 12-month price target of $73.

Foolish Takeaway

I don't think broker buy ratings on ASX shares should ever be followed blindly, but when expert views line up with improving fundamentals and depressed share prices, I do think they are worth paying attention to.

In all three cases, I can see why analysts are becoming more constructive. The risks are still there, but the balance between downside and long-term opportunity looks more attractive than it did a year ago.

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, WiseTech Global, and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Endeavour, Magellan, and Rio Tinto shares

The team at Morgans has been running the rule over these shares recently.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Should you buy Coles, Light & Wonder, and TPG Telecom shares in April?

Let's see if the team at Morgans rates these shares as buys ahead of the new month.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »